Company:
News and Publications
Knowledge and perspectives are most powerful when they are communicated to many. Through the depth of our work and wide industry exposure, Putnam Associates uncovers the strategic questions and commercialization challenges that confront drugs, diagnostics and biomedical products. Our news and publications address these issues and share the information that leads to better-informed decisions. Learn more about our growth, ideas and successes:
News:
BIO SmartBrief interviewed and quoted Paul Bogorad in an article entitled, "Biotechs Find Progress in Vaccine Market," February 3, 2010, by Julie Donnelly
Mass High Tech interviewed and quoted Paul Bogorad in an article entitled, "Biotechs Find Progress in Vaccine Market," February 3, 2010, by Julie Donnelly
Boston Business Journal interviewed and quoted Kevin Gorman in an article entitled, "Mass. Biotechs Eye Opening IPO Window," January 15-21, 2010, by Julie Donnelly
Mass High Tech interviewed and quoted Kevin Gorman in an article entitled, "Biotech IPOs on the Rise in Mass," January 15, 2010, by Julie Donnelly
John Gordon was a moderator and speaker at Harvard Business School's 2010 7th Annual Healthcare Conference, January 30, 2010 on "How Will IP Shape Growth?"
Eric Auger was a speaker at the 2010 Pricing for New Bio-Pharmaceutical Products Conference, January 27, 2010 on "Managed Care Contracting for New Product Launches"
Boston Business Journal (January 15-21, 2010 issue) interviewed and quoted Kevin in an article entitled, "Mass. Biotechs Eye Opening IPO Window," by Julie Donnelly. The same article appeared in Mass High Tech (January 15, 2010 issue) entitled, "Biotech IPOs on the Rise in Mass." FierceBiotech, the Biotech Industry's Daily Monitor, quoted Kevin Gorman in the article, "Does an M&A Flurry Presage a Blizzard of New Deals?" November 11, 2009, by John Carroll, Editor-in-Chief
The Boston Globe interviewed and quoted Kevin Gorman in the article, "Looking for Partners: French Drug Maker Says It's Eager to Work with Boston-Area Companies," November 11, 2009, by Robert Weisman
For the 6th year, Putnam Associates Named One of Top 50 Strategy Consulting Firms
The Boston Globe interviewed and quoted Kevin Gorman in the article, "Buying Binge Hits Biotech Firms," September 22, 2009, by Robert Weisman
FierceBiotech, the Biotech Industry's Daily Monitor, quoted Kevin Gorman in the article, "Does an M&A Flurry Presage a Blizzard of New Deals?" September 22, 2009, by John Carroll, Editor-in-Chief
Paul Bogorad, Ph.D. is a speaker discussing healthcare comparative effectiveness reviews at the 2009 Healthcare Deal Making Summit, "Positioning the Healthcare Organization for an Era of Reform," September 21-22, 2009. Among the wide variety of speakers at this conference are Senator Thomas Daschle and Senator Robert F. Bennett
The Wall Street Journal Online interviewed and quoted Kevin Gorman in an article entitled, "Amgen Hiring Mobile Reps in Building Bone Drug Sales Force," September 17, 2009, by Thomas Gryta
The Boston Globe interviewed and quoted Kevin Gorman in the article entitled, "FDA Seeks Contingency Details from Genzyme / Availability of Firm's Orphan Drugs is Concern for Agency," August 13, 2009, by Robert Weisman
The Boston Globe interviewed Kevin Gorman and quoted him on Epix Pharmaceuticals' bankruptcy in the article entitled, "Epix Pharmaceuticals is Latest Biotech to Fall," July 22, 2009, by Robert Weisman
The Boston Globe interviewed and quoted Domenick Bertelli on Biopure bankruptcy in the article entitled, "Biopure Files Chapter 11, Plans Sale," July 18, 2009, by D.C. Denison
Boston Business Journal interviewed Kevin Gorman and quoted him in the article "Bio Companies Come to Grips with Gift Ban," June 26-July 2, 2009, by Julie Donnelly
The Boston Globe interviewed Kevin Gorman and Domenick Bertelli and quoted them in a front-page feature article entitled, "Virus Shuts Genzyme Plant, Holds Up Drugs for 8,000," by Erin Ailworth and Robert Weisman, June 17, 2009
Boston Business Journal published Domenick Bertelli's comments on the diabetes and obesity market in "Bay State Biotech Firms Targeting the Fat of the Land," by Julie M. Donnelly, June 5-11, 2009
Kevin J. Gorman, Managing Partner, is chair and panelist of "The Struggle to Maintain Global Market Access for Innovative Biologic Products: Strategic, Economic and Product Security Perspectives" at 2009 BIO (Biotechnology Industry Organization) International Convention
In celebration of its 20th anniversary, Putnam Associates has published The First Twenty Years Are the Hardest: Two Decades in Healthcare Strategy, a collection of perspectives from a cross section of experts in healthcare
Domenick Bertelli Promoted to Partner
Putnam Associates Reports on Leveraging Physician Segmentation to Develop Brand Strategy
Forbes.com published Kevin Gorman's comments on "Health Care Policy: Will Reform Become Reality," the panel discussion in which he spoke at the 2009 Annual Wharton Health Care Business Conference, "Catalyzing Change: Accelerating Health Care Advancement." Knowledge®Wharton is the author of this article entitled, "Health Reform is Nigh," (March 5, 2009)
BioProcess International (March 2009) quoted Kevin Gorman in the chapter, "A World of Possibilities: Global/International Biotechnology Issues," on the struggle to maintain global market access for innovative biologic products including strategic, economic and product security perspectives, the topic of the panel discussion which Mr. Gorman will chair at the 2009 BIO International Convention, Atlanta, May 18-21, 2009
Knowledge@Wharton in the article, "'Major League, Middle Class Anxiety': Is the U.S. Closer to Universal Health Care?" (March 4, 2009) published Kevin Gorman's comments on "Health Care Policy: Will Reform Become Reality," the panel discussion in which he spoke at the 2009 Annual Wharton Health Care Business Conference, "Catalyzing Change: Accelerating Health Care Advancement"
Kevin J. Gorman to Speak at Wharton's 2009 Health Care Business Conference, February 20, 2009
Interview with Kevin Gorman and Domenick Bertelli in Specialty Pharmacy News, "Some Early Efforts Under Obama Could Impact Specialty Pharmacy," November 2008
Interview with Kevin Gorman and Domenick Bertelli in Specialty Pharmacy News, "Economic Downturn Hits Specialty Industry Hard; Stakeholder Responses Are Varied," November 2008
Interview with Kevin Gorman and Paul Bogorad in Drug Benefit News, "Removal of Ranbaxy Generic Rxsls Not Likely to Have Major Impact", October 3, 2008
Interview with Kevin Gorman in Drug Benefit News, "Weak Economy, Cash-Strapped Consumers May Take Toll on Pharmaceutical Benefits", October 3, 2008
Interview with Eric Auger and Ricky Joshi in Specialty Pharmacy News, "Psoriasis Can Have Significant Health Impact; Plan Understanding May Be Lacking," July 2008
Putnam Associates Celebrates Its 20th Anniversary
Interview with Richard Tinsley and Paul Bogorad in Specialty Pharmacy News, "Multiple Copays, Management Tools May Influence Influence HIV/AIDS Patients' Compliance," April 2008
Interview with John Baskey in Pharmaceutical Commerce, "Generic Manufacturers Plan Aggressive Challenges of Branded Products During 2008-2016: Paragraph IV challenges already target 57% of potential remaining product sales," January-February 2008 issue
Interview with Kevin Gorman and Domenick Bertelli in Specialty Pharmacy News, "Outlook 2008: HIV, Oncology are Among Areas That Will See Therapeutic Impact," January 2008
Interview with Eric Auger in Drug Benefit News, "First Genric Protonix Hits the Market; Plans, PBMs Expect Modest Savings at First," January 18, 2008
Putnam Associates Reports on Rapidly Changing Generic Industry
Putnam Associates Study Finds Insurers Want More Prescription Drug Use
For the Fifth Year in a Row, Putnam Associates named one of the top 50 Strategy Consulting Firms
Consulting Magazine Names Putnam Associates a Leader Among Nation's Firms
Inflection Point Articles:
Leveraging Physician Segmentation to Develop Brand Strategy: Getting More From Physician SegmentationNot Your Father's Generics: How A Rapidly Changing Global Generic Industry is Challenging Lifecycle Planning
US Managed Markets: Opportunities and Risks in the Emerging Appropriate Use Paradigm
Alliance Management - Fix it Before it Breaks: Alliance Diagnostic and Repair
Nurse Practitioners and Physician Assistants: Often Untapped for Sales and Marketing Initiatives
For more information about our news and publications, email Kevin Gorman.